When in doubt should we cut it out? The role of surgery in non-small cell lung cancer

Thorax

Volumn 61, Issue 7, 2006, Pages 554-556

  Holty, J E C ^a,c,d   Gould, M K ^a,b,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPHADENECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; TREATMENT OUTCOME;

EID: 33745819954     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.060558     Document Type: Editorial

References (39)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin 2005;55:74-108.
2. Ries LAG. Influence of extent of disease, histology and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 1994;10:21-30.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
4. Sedrakyan A, van der Meulen J, O'Byrne K, et al. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004;128:414-9.
5. Mountain CF. Revisions in the international system lor staging lung cancer (special reports). Chest 1997;111:1710-7.
6. Iascone C, DeMeester TR, Albertucci M, et al. Local recurrence of resectable non-small-cell lung carcinoma of the lung. Cancer 1986;57:471-6.
7. Wada H, Tanaka F, Yanagihara K, et al. Time trends and survival after operations for primary lung cancer from 1976 through 1990. J Thorac Cardiovasc Surg 1996;112:349-55.
8. Testa T, Nahum MA, Spinelli E, et al. The 'Will Rogers Effect' on stage grading. Ann Ital Chir 1999;70:829-30.
9. Padilla J, Calvo V, Penalver JC, et al. Stage I nonsmall cell lung cancer up to 3 cm in diameter: prognostic factors. Arch Bronconeumol 2004;40:110-3.
10. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
11. Yoshino I, Baba H, Fukuyama S, et al. A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. Surgery 2002;131:S242-8.
12. Graham EA, Singer JJ. Successful removal of an entire lung for carcinoma of the bronchus. JAMA 1933;101:1371-4.
13. Geddes DM. The natural history of lung cancer: a review based on the rates of tumour growth. Br J Dis Chest 1979;73:1-17.
14. Lederle FA, Niewoehner DE. Lung cancer surgery. A critical review of the evidence. Arch Intern Med 1994;154:2397-400.
15. Morrison R, Deeley TJ, Cleland WP. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1963;1:683-4.
16. Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest 2003;123:181-7S.
17. British Thoracic Society. Lung cancer guidelines. Available at http://www.brit-thoracic.org.uk (accessed 21 March 2006).
18. National Institute for Health, Clinical Excellence (NICE). Clinical guideline 24: Lung cancer. February 2005. Available at http://www.nice.org/uk (accessed 21 March 2006).
19. Wright G, Manser RL, Byrnes G, et al. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 2006;61:597-603.
20. Mazur DJ, Hickam DH. Five-year survival curves: how much data are enough for patient-physician decision making in general surgery. Eur J Surg 1996;162:101-4.
21. Handy JR, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21-30.
22. Yoshimura H. Quality of life (QOL) versus curability for lung cancer surgery. Ann Thorac Cardiovasc Surg 2001;7:127-32.
23. Izbicki J, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung caner: results of a prospective randomized trial. Ann Surg 1998;227:138-44.
24. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-5.
25. Wu YL, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
26. Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005;34:79-87.
27. Wu CW, Hsiung CA, Lo SS, et al. Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries. EJSO 2005;31:153-7.
28. Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 2002;9:924-8.
29. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
30. Allen MS, Darling GE, Pechet TTV, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-20.
31. Mohan A, Guleria R, Pathak AK, et al. Quality of life measures in lung cancer. Indian J Cancer 2005;42:125-32.
32. Warram J. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial (a collaborative study). Cancer 1975;36:914-25.
33. Ginsberg R, Rubenstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-23.
34. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992;101:1013-8.
35. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.
36. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;215(Suppl):607-9.
37. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73:386-92.
38. Torgerson DJ, Sibbald B. Understanding controlled trials. What is a patient preference trial? BMJ 1998;316:360.
39. Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early stage lung cancer. N Engl J Med 1999;341:1198-205.